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Association between incarceration and
incident cardiovascular disease events:
results from the CARDIA cohort study
Jordan Coleman1, Donald M. Lloyd-Jones1, Hongyan Ning1, Norrina B. Allen1, Catarina I. Kiefe2, Emily A. Wang3 and
Mark D. Huffman1,4*
Abstract
Background: Incarceration has been associated with higher cardiovascular risk, yet data evaluating its association
with cardiovascular disease events are limited. The study objective was to evaluate the association between
incarceration and incident fatal and non-fatal cardiovascular disease (CVD) events.
Methods: Black and white adults from the community-based Coronary Artery Risk Development in Young Adult
(CARDIA) study (baseline 1985–86, n = 5105) were followed through August 2017. Self-reported incarceration was
measured at baseline (1985–1986) and Year 2 (1987–1988), and fatal and non-fatal cardiovascular disease events,
including coronary heart disease, stroke, and heart failure, and all-cause mortality, were captured through 2017.
Analyses were completed in September 2019. Cumulative CVD incidence rates and Cox proportional hazards were
compared overall by incarceration status. An interaction between incarceration and race was identified, so results
were also analyzed by sex-race groups.
Results: 351 (6.9%) CARDIA participants reported a history of incarceration. Over 29.0 years mean follow-up, CVD
incidence rate was 3.52 per 1000 person-years in participants with a history of incarceration versus 2.12 per 1000
person-years in participants without a history of incarceration (adjusted HR = 1.33 [95% CI, 0.90–1.95]). Among white
men, incarceration was associated with higher risk of incident cardiovascular disease (adjusted HR = 3.35 [95% CI,
1.54–7.29) and all-cause mortality (adjusted HR = 2.52 [95% CI, 1.32–4.83]), but these associations were not
statistically significant among other sex-race groups after adjustment.
Conclusions: Incarceration was associated with incident cardiovascular disease rates, but associations were only
significant in one sex-race group after multivariable adjustment.
Keywords: Incarceration, Cardiovascular disease, Epidemiology
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Background
The United States has the world’s highest incarceration
rate, and incarceration rates have increased dramatically
over the past 30 years, especially among some sex-race/
ethnic groups [1]. For example, the lifetime risk for
incarceration is estimated to be 1 in 3 among Black men
and 1 in 6 among Hispanic/Latino men [2]. Cardiovascu-
lar disease (CVD) is the leading cause of death among the
estimated 2.2 million individuals who are incarcerated in
the United States [3]. Following release from incarcer-
ation, CVDs are the leading causes of hospitalization
among those recently incarcerated [4]. Longitudinal
community-based cohort studies have demonstrated an
association between incarceration and risk factors for
CVD, including incident hypertension, as well as corre-
sponding cardiac structural changes [5]. Mechanisms
relating incarceration to CVD have been proposed by a
National Heart, Lung, and Blood Institute workshop com-
mittee, including socio-demographic factors associated
with disproportionate CVD risk, stress and mental health
associated with incarceration, potentially unhealthy behav-
iors and limited health care during incarceration leading
to increased burden of CVD risk factors, and poorer
health care access following release [3]. However, to our
knowledge, longitudinal, community-based cohort data
exploring the relationship between incarceration and inci-
dent CVD events have not been published. Therefore, the
objective of this analysis was to evaluate the long-term as-
sociation between adult incarceration history and incident
fatal and non-fatal CVD events among white and Black
participants in the Coronary Artery Risk Development in
Young Adults community-based cohort study.
Methods
Sample
The Coronary Artery Risk Development in Young Adults
(CARDIA) cohort study enrolled 5115 black and white
men and women between 18 and 30 years old and who
were free from CVD at baseline in 1985–1986 [6]. Partici-
pants were recruited from Chicago, Illinois; Birmingham,
Alabama; Oakland, California; and Minneapolis, Minnesota.
The sampling methods resulted in a baseline cohort
balanced in terms of age, sex, race, and education. Investi-
gators have re-examined participants at in-person examina-
tions at years 2, 5, 7, 10, 15, 20, 25, and 30 (2015–16).
Retention rates among surviving participants at each in-
person examination were 91, 86, 81, 79, 74, 72, 72, and
71%, respectively. Contact is maintained with participants
via telephone, mail, or email every 6months, with annual,
interim medical history ascertainment. Over the last 5 years,
> 90% of surviving cohort members have been directly con-
tacted, and follow-up for vital status is virtually complete
through related contacts and intermittent National Death
Index searches. All CARDIA participants included in this
study provided informed consent. The CARDIA study has
been reviewed and approved by the Institutional Review
Boards of all participating institutions.
Among 5115 CARDIA participants, we excluded 6
participants with cardiovascular disease events at or
prior to Exam 2, 2 participants who were transgender, 1
participant who withdrew consent, and 1 participant
without a response to incarceration history. We included
5105 participants in the analysis (Supplemental Figure).
Ascertainment of incarceration
CARDIA participants were assessed on their history of
incarceration at two time points. At baseline and Year 2
examinations, participants were asked, “During the past
year, did any of the following happen to you?” with
“Went to jail” one of the options. The Year 2 follow-up
examination allowed individuals to report any incarcer-
ation event that happened since baseline, although no
similar questions were asked at subsequent exams.
Recorded responses to these two questions allowed for
the creation of an incarceration exposure variable to
account for any reported time spent in jail (generally
considered < 1 year of incarceration) or prison (1 year or
greater period of incarceration) from 1 year prior to the
study through the Year 2 examination. Among partici-
pants who reported more than 1 incarceration event, the
earliest incarceration date was selected as the exposure
of interest. No reasons for incarceration were captured.
Measurement of cardiovascular disease risk factors
Trained study personnel captured socio-demographic,
behavioral, and CVD risk factor data at each exam with
quality control protocols in place. Age, sex, race/ethni-
city, highest education level, and annual family income
were self-reported. Baseline annual family income below
$24,999 per year was defined as low socioeconomic pos-
ition by meeting the 250% federal poverty line in 1985 [7].
Smoking history was assessed using a questionnaire
administered by interviewers. Heavy alcohol intake was
defined using the National Institute on Alcohol Abuse
and Alcoholism thresholds (> 14 drinks/week for men;
or > 7 drinks/week for women) [8]. Information about
illicit drug use was obtained through interview-style
questionnaires that asked specifically about use of
cocaine and amphetamines. Participants were considered
current users if they had used in the past month. Physical
activity information was collected using an interviewer-
administrated CARDIA Physical Activity History question-
naire that asked about 13 specific activities over the course
of the prior year [9].
CVD risk factors were recorded at baseline and at sub-
sequent exams. For measurement of body mass index,
trained and certified technicians weighed participants
using a standard balance beam scale while wearing light
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clothing. A wall-mounted stadiometer was used for
height measurements, which were recorded to the near-
est half centimeter. Participants’ blood pressures were
recorded using a random zero sphygmomanometer.
Both systolic and diastolic blood pressures were re-
corded three times at an interval of 1 minute, and the
mean of the last 2 measures was recorded. Fasting serum
total cholesterol and high-density lipoprotein cholesterol
levels were measured enzymatically from plasma
venipuncture samples stored at -70 °C. The Friedewald
equation was used to calculate low-density lipoprotein
cholesterol levels. Fasting plasma glucose levels were
also measured from stored samples. Data were captured
about medical history and blood pressure, cholesterol,
and diabetes medications.
Outcome ascertainment
Ascertainment of fatal and non-fatal CVD events, in-
cluding coronary heart disease, stroke, and heart failure,
and all-cause mortality was performed annually between
baseline to the present through telephonic follow-up, in-
person examinations, and review of National Death
Index database (details at: http://www.cardia.dopm.uab.
edu). Hospital records were sought for self-reported
outcomes, and central adjudication was performed by
trained physicians to ascertain CVD events. The last date
of follow-up for this analysis was August 31, 2017.
Statistical analysis
CARDIA participants with and without a self-reported
history of adult incarceration exposure were compared
in terms of socio-demographics, behaviors, medical
history, and CVD risk factors. Cumulative composite
CVD event incidence rates, including fatal and non-fatal
coronary heart disease, stroke, and heart failure, and all-
cause mortality were assessed beginning after the Year 2
examination to capture exposure data prior to any
events. We also explored the association between incar-
ceration and coronary heart disease, stroke, and heart
failure separately. We created unadjusted and adjusted
Cox proportional hazards models after confirming that
the proportionality assumption was met. Participants
who died from non-cardiovascular causes were censored
from the analyses at their date of death. We first
adjusted for baseline age, sex, race/ethnicity and then
adjusted for baseline education, smoking, excessive
alcohol consumption, physical activity, body mass index,
systolic blood pressure, use of blood pressure lowering
medication, total and high-density lipoprotein choles-
terol, and field center. Variance Inflation Factors were
calculated to diagnose collinearity between multiple
variables and were well below values indicative of multi-
collinearity (range: 1.04–1.37). We report the results of
the complete case analysis as the primary analysis due to
the low rate of missingness (0.2%) of these exposure
data. As part of our standard analyses of the models, we
identified an interaction between incarceration and race
with incident cardiovascular disease by calculating the
relative excess risk for interaction, which was significant
on both additive and multiplicative scales. We observed
the significant interaction term of race and incarcer-
ation, and therefore, report these exploratory, post hoc
results by sex-race strata for incident cardiovascular dis-
ease and all-cause mortality. There were too few events
in subtypes of cardiovascular disease events among some
sex-race groups to create stable model estimates so we
do not report these results. We also performed post hoc
sensitivity analyses using competing Cox models to ac-
count for the potential influence of competing risk of
death due to non-CVD causes since risk of death from
non-CVD causes may vary by incarceration status [10].
SAS v 9.4 (Cary, NC) was used for statistical analyses.
Analyses were completed in September 2019. A two-sided
P value < 0.05 was used to define statistical significance.
Role of funding source
The sponsor did not participate in the current study
design; in the collection, analysis, and interpretation of
data; in the writing of the report; and in the decision to
submit the paper for publication.
Results
Participants
Among the eligible sample (5114 participants; 1 partici-
pant rescinded consent for participation), we included
5105 participants (99.8%) in our analyses because 9 partic-
ipants either experienced an event, were lost to follow-up,
or underwent gender reassignment between the baseline
examination and Year 2 follow-up.
Adult incarceration
Of the 351 (6.9%) CARDIA participants who reported a
history of incarceration, 155 (44%) reported having been
in jail in the year prior to enrolling in the study, and 136
(39%) responded yes to the question at the Year 2 exam-
ination, indicating they had been incarcerated between
the start of the study and Year 2 (Table S1). Sixty (17%)
participants responded yes to the question on both
forms, identifying multiple incarceration exposures.
Table 1 shows the baseline characteristics of the
sample, stratified by incarceration history. Compared
with participants without a history of incarceration,
participants with a history of incarceration were signifi-
cantly younger and more likely to be male, Black, have a
lower level of education and have an annual family in-
come less than $25,000 at baseline. Participants with a
history of incarceration were also more likely to smoke
at baseline, have heavy alcohol use, report illicit drug
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use, and have a higher baseline systolic blood pressure.
Serum low-density lipoprotein and high-density lipopro-
tein cholesterol and fasting plasma glucose levels were
similar between groups.
Primary analysis
Over mean follow-up of 29.0 years, there were 313 cases
of incident CVD events identified: 33 among participants
with a history of incarceration, and 280 among partici-
pants without a history of incarceration (9.4% versus
5.9%, P = 0.008, Table S2). The most common event was
incident coronary heart disease among both groups. The
incidence rate for CVD was 3.52 per 1000 person-years
in participants with a history of incarceration compared
with 2.12 per 1000 person-years (p = 0.03) in participants
without a history of incarceration (unadjusted hazard
ratio, HR = 1.69; 95% confidence intervals [CI] 1.18–
2.42; Fig. 1).
After adjustment, the association was no longer statisti-
cally significant (adjusted HR = 1.33 [95% CI, 0.90–1.95]) in
the overall cohort. The direction and magnitude of findings
were similar for all-cause mortality. The association be-
tween incarceration and incident CVD was also similar
after accounting for the competing risk of non-CVD death
(adjusted HR = 1.28 [95% CI, 0.86–1.91], Table S3).
Secondary analyses
We stratified analyses by sex and race after identifying
an interaction between incarceration and race with inci-
dent CVD, and report event rates by sex-race group in
Table 2. Baseline characteristics according to sex-race
group and incarceration status are reported in Table S4.
Among white men, participants with a history of incar-
ceration experienced a higher rate of incident CVD com-
pared with those without a history of incarceration
(13.7% versus 6.22%, P = 0.01); this finding was not ob-
served among Black men (8.2% versus 8.9%, P = 0.74),
who were at the overall highest risk for CVD, nor among
women of either race. The incidence rate for CVD was
5.20 per 1000 person-years among white men with a
history of incarceration compared with 2.25 per 1000
person-years among white men without a history of in-
carceration (adjusted HR = 3.35 [95% CI, 1.54–7.29],
Table 3). Among other sex-race groups with a history of
incarceration, there was no statistically significant associ-
ation with incident CVD (Black men, adjusted HR = 0.82






Age, mean (SD), years 24.0 (3.7) 24.9 (3.6) <.0001
Male sex, No. (%) 268 (76.4) 2054 (43.2) <.0001
Black race, No. (%) 254 (72.4) 2379 (50.0) <.0001
Education, mean (SD), years 12.4 (1.8) 13.9 (2.3) <.0001
Individual annual income <$25,000, No. (%)a 173 (61.8) 1462 (36.7) <.0001
Smoker, No. (%) 190 (55.1) 1351 (28.6) <.0001
Heavy alcohol use, No. (%) 98 (28.0) 550 (11.6) <.0001
Illicit drug use, No. (%)b 86 (26.5) 312 (7.3) <.0001
Heavy or moderate exercise, median (IQR), MET-minutes per week 443 (254, 714) 356 (192, 571) < 0.001
Body mass index, mean (SD), kg/m2 24.1 (4.3) 24.5 (5.1) 0.11
Systolic blood pressure, mean (SD), mmHg 113.1 (11.4) 110.2 (10.9) <.0001
Diastolic blood pressure, mean (SD), mmHg 69.0 (10.7) 68.6 (9.5) 0.38
Blood pressure medication, No. (%) 8 (2.3) 107 (2.3) 0.85
Total cholesterol, mean (SD), mg/dl 175.4 (34.9) 176.9 (33.4) 0.43
Low density lipoprotein cholesterol, mean (SD), mg/dl 106.1 (32.1) 109.3 (31.1) 0.06
High density lipoprotein cholesterol, mean (SD), mg/dl 54.1 (14.7) 53.1 (13.1) 0.17
Triglycerides, median (IQR), mg/dl 65 (47.5, 90.5) 62 (45, 84) 0.04
Fasting plasma glucose, mean (SD), mg/dl 83.4 (9.4) 82.5 (16.7) 0.36




a836 (16%) participants did not respond to this question
b532 (10%) participants did not respond to this question
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[95% CI, 0.44–1.52]; white women, adjusted HR = 1.60
[95% CI, 0.20–12.57]; Black women, adjusted HR = 1.22
[95% CI, 0.44–3.40]. Incarceration was also associated
with all-cause mortality in white men (adjusted HR =




We demonstrated a higher rate of incident CVD over a
29-year period of follow-up among individuals with a
history of incarceration in a community-based cohort,
although this finding was no longer statistically signifi-
cant after multivariable adjustment in most sex-race
groups. Results were similar for all-cause mortality. In
post hoc analyses, the association between incarceration
and incident CVD and all-cause mortality was evident
among white men, but not among other sex-race
groups.
Mechanisms of the proposed relationship relate to in-
dividual-, family- and community-level factors before,
during, and after incarceration [3]. First, individuals,
families, and communities with lower socioeconomic
position have higher levels of CVD and common CVD
risk factors because of fewer “flexible resources” for
healthier living based on the fundamental cause theory
[11]. Lower socioeconomic position groups also have
disproportionate rates of incarceration, which can
exacerbate stress, depression, and mental illness. While
incarcerated, individuals face variability in the availability
and quality of clinical care available, sedentarism and
unhealthy diets that can worsen CVD risk factors, and
Fig. 1 Hazard Ratios for Incident Fatal and Non-fatal Cardiovascular Diseases According to Incarceration History Status, CARDIA Study: 1985–2017
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limited autonomy and self-efficacy to manage health
conditions. Following release, previously-incarcerated in-
dividuals often return to resource-limited communities
and face further socioeconomic disadvantage because of
their history of incarceration, based on policies that may
limit job and educational grant opportunities [3].
The observed attenuation of the unadjusted associ-
ation and sex-race differences may be driven by several
factors. First, while it is possible that no association ex-
ists, the small number of events among individuals with
a prior history of incarceration suggests that this rela-
tionship may be underpowered to detect such an overall
association after adjustment in all sex-race groups. The
hypothesized relationship may be mediated through
CVD risk factors included in the multivariable models,
which explains the attenuation after adjustment. For
example, a 2020 systematic review of 26 longitudinal
studies demonstrated that incarcerated individuals were
gained, on average, 5.3 kg (95% CI: 0.5–10.1 kg) in
weight during their period of incarceration, though the
trends in other risk factors were less clear [12]. Second,
losses to follow-up among Black men were higher than
among other sex-race groups, and up to 65% of those
losses at later examinations may have been due to
incarceration [13], which limits the ability to capture
non-fatal cardiovascular disease events occurring during
incarceration, including among those with a history of
incarceration. Third, other sociodemographic factors, in-
cluding poverty, stress, and social disadvantage may be
collinear with race/ethnicity and attenuate an associ-
ation, though we adjusted for education as a marker for
socioeconomic position. However, these relationships
are complex and difficult to identify the independent
contribution of each to the hypothesized relationship.
Fourth, CVD event rates were higher among Black men
and women, including in the unexposed groups. For ex-
ample, compared with white men, Black men had a 48%
higher rate of incident CVD. White men with a history
of incarceration also had a higher risk for all-cause mor-
tality compared with white men without incarceration,
but this rate was 51% lower compared with the all-cause
mortality rate among Black men. Fifth, ascertainment of
the exposure did not differentiate between incarceration
type or length, and there may be a differential pattern of
association based on these exposure-level factors. Sixth,
post-release neighborhood disadvantage may be rela-
tively greater among former inmates who are white com-
pared with other race/ethnic groups after controlling for
pre-prison characteristics based on the National Longi-
tudinal Survey of Youth [14]. Finally, there was likely
some misclassification of incarceration status, because of
under-reporting of incarceration due to social desirabil-
ity bias or because some individuals may have been in-
carcerated > 1 year before the baseline examination or
after the time of the Year 2 examination, or could not
attend the Year 2 examination, any of which would have
tended to bias our findings of an association between in-
carceration and incident CVD events toward the null,
particularly among Black men.
Comparison with prior studies
Previous research has demonstrated associations be-
tween prior incarceration and higher burden of CVD
risk factors and subclinical CVD, including weight gain
during incarceration [12] and incident hypertension and
post-release hospitalization due to CVDs [4, 5]. For example,
Table 3 Hazard Ratios for Incident Fatal and Non-fatal Cardiovascular Diseases and All-Cause Mortality According to Incarceration
History Status, Stratified by Sex and Race, CARDIA Study
Event n/N Rate per 1000 person-years,
incarceration history









White Men 78/1167 5.20 2.25 2.40 (1.23–4.66) 2.87 (1.48–5.62) 3.35 (1.54–7.29)
Black Men 102/1155 3.13 3.33 0.94 (0.55–1.61) 1.01 (0.59–1.73) 0.82 (0.44–1.52)
White Women 38/1305 1.44 1.02 1.40 (0.19–10.18) 1.45 (0.20–10.57) 1.60 (0.20–12.57)
Black Women 95/1478 3.66 1.20 1.63 (0.71–3.72) 1.66 (0.73–3.80) 1.22 (0.44–3.40)
All-cause mortality
White Men 91/1167 6.53 2.54 2.60 (1.44–4.67) 2.89 (1.60–5.22) 2.52 (1.32–4.83)
Black Men 167/1155 6.15 5.14 1.23 (0.83–1.80) 1.29 (0.88–1.90) 0.92 (0.55–1.52)
White Women 64/1305 1.44 1.72 0.83 (0.12–6.00) 0.87 (0.12–6.24) 0.63 (0.08–4.87)
Black Women 109/1478 4.19 2.54 1.49 (0.69–3.23) 1.54 (0.71–3.35) 1.24 (0.49–3.13)
Model 1: Unadjusted
Model 2: Adjusted for baseline age
Model 3: Adjusted for baseline age, sex, race, baseline education, baseline smoking, baseline excessive alcohol use, baseline physical activity, baseline body mass
index, baseline systolic blood pressure, baseline blood pressure lowering medication use, baseline total cholesterol, and baseline high density
lipoprotein cholesterol
HR hazard ratio, CI confidence intervals
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CARDIA data demonstrate a 1.7-fold higher odds of
incident hypertension and a 2.7-fold higher odds of left
ventricular hypertrophy among those with a history of incar-
ceration [5]. Individuals with a history of incarceration also
had a 2.5 higher odds of not having access to regular
medical care. Among Medicare beneficiaries with a recent
incarceration event, the odds of hospitalization were 2.5, 2.1,
and 1.8 times higher at 7, 30, and 90 days post-release,
respectively, compared with matched controls, including
CVD hospitalization [4]. However, these individuals were
more likely to be Medicare beneficiaries based on disability
status or end-stage renal disease compared with the general
Medicare population. A 15.5-year follow-up linkage study
among 23,510 previously incarcerated individuals in Georgia
(95% men, 67% Black) demonstrated a 1.77 (95% CI, 1.67–
1.88) higher standardized mortality risk compared with non-
incarcerated Georgians [15]. The authors estimated that
62% of the excess post-release risk was due to HIV, cancer,
homicide, transportation-related injury, and accidental poi-
soning; heart disease rates were not higher among previously
incarcerated individuals than expected, after adjustment.
Higher rates have been reported, including a 3.5-fold (95%
CI, 3.2–3.8) higher mortality rate observed among previ-
ously incarcerated individuals in Washington state, where a
2.1-fold (95%CI, 1.6%-2.1) higher CVD-related mortality rate
was observed over a mean follow-up of 1.9 years [16].
Other research has reported a higher risk for self-
reported obesity, CVD, and fair or poor health among
women who have a family member incarcerated [17],
demonstrating the broad influence of incarceration on
family health. Neighborhood incarceration rates are as-
sociated with CVD risk factors, which suggests potential
environmental drivers of health behaviors and factors
prior to and following incarceration [18]. A 2018 system-
atic review of 11 studies summarized the role of inter-
ventions to improve health behaviors and factors among
individuals during their incarceration, including group-
based interventions to improve activity, nutrition, blood
pressure, cholesterol, and smoking cessation [19]. While
risk factor management during incarceration may help
reduce long-term risks, residual risk factor exposure
prior to incarceration, accumulation following release,
and differential access to health care may influence long-
term outcomes.
This study provides unique, community-based, longi-
tudinal data reporting on the long-term relationship be-
tween incarceration and CVD events. Whether these
associations are independent of risk factors that operate
within the known causal pathway for incident CVD or
also operate more broadly in terms of differences in
early life exposures, social, environmental, or behavioral
factors, and access to and quality of preventive and acute
treatment is uncertain but plausible. At a minimum,
our data demonstrate potential CVD-related hazards
of incarceration and suggest the need for primordial
and primary CVD prevention among incarcerated
young adults, and further research to quantify risks
more precisely and to identify successful prevention
strategies.
Strengths and limitations
This study has several strengths, including a recruiting a
large bi-racial, community-based sample with rigorous
30 year follow-up. This study also has limitations,
including limited number of events in two race/ethnic
groups and thus power to detection a potential associ-
ation, as well as risk of recall bias, leading to underre-
porting of previous incarceration, though this would
likely attenuate any potential associations. While CAR-
DIA used robust methods to capture events, some non-
fatal CVD events may not have been captured, especially
among Black men in whom losses to follow-up were dis-
proportionately higher due to incarceration. Analyses
aimed to adjust for confounders as well as risk factors
that operate within the causal pathway, which may lead
to over-adjustment. Analyses did not adjust for factors
that may have influenced access to medical care, such as
health insurance, which was not captured at baseline.
We sought to minimize missingness of covariates in our
models by selecting parsimonious models, but this may
have influenced these results. This study sought to
establish an association between incarceration and inci-
dent CVD, and the observed associations among white
men may be due to chance given the post hoc nature of
these analyses and should be interpreted with caution.
We did not explore the potential influence of length or
cause of incarceration, which may affect these results.
We did not capture data on incarcerations earlier or
later in adulthood, so not all incarceration exposures
were captured, which may attenuate or abrogate a potential
association. On the other hand, this potential misclassifica-
tion could also bias the results of a potential association be-
tween incarceration and incident cardiovascular disease
events toward the null. It remains uncertain if avoiding or
reducing incarceration would lower the incidence of CVD,
although there are other, arguably larger, individual and
societal benefits to minimizing incarceration.
Conclusions
A history of incarceration was associated with incident
CVD event rates overall in a young, biracial community-
based cohort study, but this relationship was significant
after multivariable adjustment in some sex-race groups.
These provocative data merit careful interpretation and
replication in other studies to understand their full
implications, and further research in larger cohorts or with
longer follow up may improve precision of these estimates,
and indicate potential reasons underlying the associations.
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